CDC’s COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions

Author:

Soeters Heidi M.,Doshi Reena H.,Fleming Monica,Adegoke Oluwasegun Joel,Ajene Uzoamaka,Aksnes Brooke Noel,Bennett Sarah,Blau Erin F.,Carlton Julie Garon,Clements Sara,Conklin Laura,Dahlke Melissa,Duca Lindsey M.,Feldstein Leora R.,Gidudu Jane F.,Grant Gavin,Hercules Margaret,Igboh Ledor S.,Ishizumi Atsuyoshi,Jacenko Sara,Kerr Yinka,Konne Nuadum M.,Kulkarni Shibani,Kumar Archana,Lafond Kathryn E.,Lam Eugene,Longley Ashley T.,McCarron Margaret,Namageyo-Funa Apophia,Ortiz Nancy,Patel Jaymin C.,Perry Robert T.,Prybylski Dimitri,Reddi Prianca,Salman Omar,Sciarratta Courtney N.,Shragai Talya,Siddula Akshita,Sikare Ester,Tchoualeu Dieula Delissaint,Traicoff Denise,Tuttle Alexandra,Victory Kerton R.,Wallace Aaron,Ward Kirsten,Wong Man Kai Alyssa,Zhou Weigong,Schluter W. William,Fitter David L.,Mounts Anthony,Bresee Joseph S.,Hyde Terri B.

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference47 articles.

1. UK Coronavirus Dashboard. Coronavirus (COVID-19) in the UK—vaccinations. 2021 [cited 2021 Sep 2]. https://coronavirus.data.gov.uk/details/vaccinations

2. Demographic characteristics of persons vaccinated during the first month of the COVID-19 vaccination program—United States, December 14, 2020–January 14, 2021.;Painter;MMWR Morb Mortal Wkly Rep,2021

3. World Health Organization. Interim recommendations for use of the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, under emergency use listing: interim guidance, 8 January 2021. 2021 [cited 2021 Sep 2]. https://apps.who.int/iris/handle/10665/338484

4. World Health Organization. WHO coronavirus (COVID-19) dashboard. 2022 [cited 2022 Apr 4]. https://covid19.who.int

5. World Health Organization. Coronavirus disease (COVID-19). WHO—prequalification of medical products. 2022 [cited 2022 Apr 4]. https://extranet.who.int/pqweb/vaccines/covid-19-vaccines

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Global Responses to the COVID-19 Pandemic;Emerging Infectious Diseases;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3